| Literature DB >> 24699750 |
Kim-Hung Huynh1, Huyen-Thi Tran2, Tan-Viet Pham2, Ho-Phuong-Thuy Ngo1, Sun-Shin Cha3, Kyung Min Chung4, Sang Hee Lee5, Lin-Woo Kang1.
Abstract
Acinetobacter baumannii causes bacteraemia, pneumonia, other respiratory-tract and urinary-tract infections in humans. OXA-23 carbapenemase-producing A. baumannii K0420859 (A. baumannii OXA-23) is resistant to carbapenem, a common antibacterial drug. To develop an efficient and novel antibacterial drug against A. baumannii OXA-23, D-alanine-D-alanine ligase, which is essential in bacterial cell-wall synthesis, is of interest. Here, the D-alanine-D-alanine ligase (AbDdl) gene from A. baumannii OXA-23 was cloned and expressed, and the AbDdl protein was purified and crystallized; this enzyme can be used as a novel target for an antibacterial drug against A. baumannii OXA-23. The AbDdl crystal diffracted to a resolution of 2.8 Å and belonged to the orthorhombic space group P212121, with unit-cell parameters a = 113.4, b = 116.7, c = 176.5 Å, a corresponding VM of 2.8 Å(3) Da(-1) and a solvent content of 56.3%, and six protomers in the asymmetric unit.Entities:
Keywords: OXA-23-producing Acinetobacter baumannii; cell-wall synthesis; d-alanine-d-alanine ligase
Mesh:
Substances:
Year: 2014 PMID: 24699750 PMCID: PMC3976074 DOI: 10.1107/S2053230X14005081
Source DB: PubMed Journal: Acta Crystallogr F Struct Biol Commun ISSN: 2053-230X Impact factor: 1.056